Symptoms and Warning Signs of MPI-CDG
At a Glance
MPI-CDG can cause early diarrhea and vomiting, liver problems, unpredictable low blood sugar, and both bleeding and clotting risks. Caregivers should follow the child’s rescue plan and seek emergency help for severe low blood sugar, clots, or major bleeding.
While MPI-CDG is highly treatable, recognizing its symptoms is essential for managing the condition and knowing when to seek help. Because this disorder involves the processing of sugars throughout the body, its symptoms can appear in several different systems at once, primarily the digestive tract, the liver, and the blood [1][2].
Digestive and Liver Symptoms
The gastrointestinal (GI) and liver symptoms of MPI-CDG often appear in infancy or early childhood, usually before age two [1].
- Chronic Diarrhea and Vomiting: These are the most common early signs, reported in the vast majority of children with the condition [1][3].
- Protein-Losing Enteropathy (PLE): This occurs when the gut cannot properly retain proteins, causing them to “leak” out of the body [1][4]. This often leads to hypoalbuminemia (low levels of the protein albumin in the blood) and edema (swelling), which may look like puffiness in the face, legs, or abdomen [1][5].
- Liver Enlargement (Hepatomegaly): Doctors may feel an enlarged liver during a physical exam. Blood tests may also show elevated liver enzymes, and some children develop fibrosis (liver scarring) [1][3]. Even when other symptoms improve with treatment, the liver may require long-term monitoring for signs of portal hypertension (increased pressure in the veins leading to the liver) [4][3].
Blood Sugar and Clotting Issues
MPI-CDG affects how the body manages insulin and how the blood clots.
- Hyperinsulinemic Hypoglycemia: This is a form of low blood sugar caused by the body releasing too much insulin [1][5]. It can be very unpredictable and may require specialized care to stabilize [5][6].
- Coagulopathy (Clotting Problems): The body may not produce enough of the proteins that help the blood clot properly, such as antithrombin, protein C, and protein S [7][1]. Paradoxically, while this can sometimes make lab tests look like the blood is “thin,” it actually increases the risk of dangerous blood clots [7][5]. MPI-CDG produces a complex state where patients face both bleeding and clotting risks simultaneously.
When to Contact Your Medical Team
You should contact your child’s specialist the same day if you notice:
- An increase in the frequency or severity of diarrhea or vomiting [4].
- New or worsening swelling (edema) in the limbs or face [5].
- Signs of mild low blood sugar, such as unusual irritability, shakiness, or sweating (follow your individualized plan for rescue treatment) [5].
- Missing a dose of D-mannose, as symptoms can begin to return quickly when treatment is interrupted [4][8].
Emergency Red Flags: When to Call Your Local Emergency Number
Some complications of MPI-CDG are medical emergencies and require immediate evaluation at the nearest emergency department.
Severe Hypoglycemia (Low Blood Sugar)
If your child’s blood sugar drops too low, it can affect their brain’s ability to function. Seek emergency help for:
- Extreme sleepiness or difficulty waking your child.
- Altered responsiveness (your child is “not themselves” or seems confused).
- Seizures or loss of consciousness [1][5].
CRITICAL FIRST-AID: Do NOT put food, liquid, or oral D-mannose in the mouth of a child who is unconscious, having a seizure, or unable to swallow safely, as this can cause choking. Place the child safely on their side. If your clinician has provided a prescribed glucagon kit as part of your individualized rescue plan, use it exactly as instructed and call your local emergency number immediately. (Note: D-mannose is a maintenance therapy, NOT a rescue treatment for acute hypoglycemia; acute hypoglycemia requires glucose/dextrose).
Thrombosis (Blood Clots) and Bleeding
Because children with MPI-CDG are at high risk for blood clots, you must watch for signs that a clot has formed in a vital area [7][1].
Cerebral Venous Sinus Thrombosis (CVST) is a rare but life-threatening blood clot in the brain. Seek emergency help for:
- A sudden, severe headache.
- New neurological changes, such as weakness on one side of the body or difficulty speaking.
- Sudden vision changes or persistent vomiting without a clear cause [7].
Other Clots: Seek emergency help for sudden swelling, redness, or warmth in a single arm or leg (signs of a Deep Vein Thrombosis or DVT), or sudden shortness of breath and chest pain [5][4].
GI Bleeding: Severe portal hypertension can lead to enlarged veins that may cause dangerous bleeding. Seek emergency care immediately for vomiting blood, black/tarry stools, or sudden massive abdominal swelling.
Always inform emergency responders and hospital staff that your child has MPI-CDG and may be at risk for both severe low blood sugar and blood clots. Provide them with your child’s metabolic emergency letter if you have one.
Common questions in this guide
What are the most common early symptoms of MPI-CDG?
What signs mean my child with MPI-CDG needs emergency help for low blood sugar?
Can MPI-CDG increase the risk of blood clots?
When should I contact my child’s MPI-CDG care team the same day?
Why does my child need ongoing liver monitoring with MPI-CDG?
What are signs of serious bleeding from MPI-CDG?
Get notified when new evidence is published on MPI-CDG.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Mannose phosphate isomerase gene mutation leads to a congenital disorder of glycosylation: A rare case report and literature review.
Lu S, Liang S, Wu Y, et al.
Frontiers in pediatrics 2023; (11()):1150367 doi:10.3389/fped.2023.1150367.
PMID: 37124179 - 2
Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation.
Čechová A, Altassan R, Borgel D, et al.
Journal of inherited metabolic disease 2020; (43(4)):671-693 doi:10.1002/jimd.12241.
PMID: 32266963 - 3
[Clinical characteristics and D-mannose treatment outcomes in 5 children with mannose phosphate isomerase-congenital disorders of glycosylation].
Zhang Y, Li LT, Wang NL, et al.
Zhonghua er ke za zhi = Chinese journal of pediatrics 2025; (63(10)):1136-1141 doi:10.3760/cma.j.cn112140-20250513-00403.
PMID: 40962549 - 4
Long term outcome of MPI-CDG patients on D-mannose therapy.
Girard M, Douillard C, Debray D, et al.
Journal of inherited metabolic disease 2020; (43(6)):1360-1369 doi:10.1002/jimd.12289.
PMID: 33098580 - 5
Protein losing enteropathy due to congenital disorder of glycosylation: A case report.
Odenthal J, Lin HC, Trieschmann K
SAGE open medical case reports 2025; (13()):2050313X251397063 doi:10.1177/2050313X251397063.
PMID: 41282383 - 6
Mannose phosphate isomerase-congenital disorder of glycosylation leads to asymptomatic hypoglycemia.
Luo C, Peng D, Li Y, et al.
Molecular genetics and metabolism reports 2024; (41()):101162 doi:10.1016/j.ymgmr.2024.101162.
PMID: 40206417 - 7
Mannose phosphate isomerase deficiency-congenital disorder of glycosylation (MPI-CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia.
Mühlhausen C, Henneke L, Schlotawa L, et al.
JIMD reports 2020; (55(1)):38-43 doi:10.1002/jmd2.12149.
PMID: 32905087 - 8
Oral D-mannose therapy during pregnancy in a woman with MPI-CDG: A case report and management review.
Martzolff L, Raynor A, Lebredonchel E, et al.
Molecular genetics and metabolism 2025; (146(4)):109269 doi:10.1016/j.ymgme.2025.109269.
PMID: 41172867
This page is for informational purposes only and does not constitute medical advice. It explains MPI-CDG warning signs, but your child’s specialist and emergency services should guide care for your child’s specific situation.